|
Ranbaxy Laboratories is quite the rainmaker in India's pharmaceutical business. The company is one of India's largest drug manufacturers and a top global generics producer. Anti-infectives amoxycillin (not to be confused with the common antibiotic, amoxicillin) and ciprofloxacin, and cardio drug simvastatin are among Ranbaxy's top sellers; all come in several administration forms. The company also makes treatments for gastrointestinal, musculoskeletal, and central nervous system disorders, as well as diabetes, pain, allergies, and HIV/AIDS. Its R&D focus includes new forms of existing drugs and metabolic disease treatments. Japanese drugmaker Daiichi Sankyo owns a controlling stake in Ranbaxy.
|
| | | Contact Information | |
Address: |
Plot 90, Sector 32
Gurgaon, Haryana 122001, India
| | Phone: | +91-124-413-5000 | | Fax: | +91-124-413-5001 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2011): | 1863.60 M | | Revenue Growth (1 yr): | (-5.30%) | | Employees (2011): | 14,042 | | Employee Growth (1 yr): | 4.60% |
|
|
Key People
| | • |
Chairman:
Tsutomu Une
| | • |
Managing Director:
Arun Sawhney
| | • |
General Manager Corporate Communications:
Krishnan Ramalingam
|
|
|
Industry Information
| |
Sector: | |
Industry: |
|
|
